Innophos Holdings, Inc. (NASDAQ:IPHS) – Equities researchers at KeyCorp issued their FY2018 EPS estimates for Innophos Holdings in a research note issued to investors on Friday. KeyCorp analyst M. Sison forecasts that the specialty chemicals company will post earnings per share of $2.65 for the year.
Innophos Holdings (NASDAQ:IPHS) last issued its quarterly earnings results on Tuesday, August 1st. The specialty chemicals company reported $0.57 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $0.52 by $0.05. The company had revenue of $179.14 million during the quarter, compared to analyst estimates of $172.65 million. Innophos Holdings had a net margin of 6.46% and a return on equity of 13.79%. Innophos Holdings’s quarterly revenue was down 1.5% compared to the same quarter last year. During the same period last year, the business earned $0.63 EPS.
Several other analysts have also commented on IPHS. Zacks Investment Research raised shares of Innophos Holdings from a “hold” rating to a “strong-buy” rating and set a $54.00 price target for the company in a research report on Tuesday. BidaskClub lowered shares of Innophos Holdings from a “hold” rating to a “sell” rating in a research report on Wednesday, July 12th. Finally, Sidoti raised shares of Innophos Holdings from a “neutral” rating to a “buy” rating in a research report on Friday, May 26th. They noted that the move was a valuation call.
Shares of Innophos Holdings (NASDAQ IPHS) traded down 0.41% on Monday, hitting $46.57. 34,933 shares of the company traded hands. The firm has a market capitalization of $903.27 million, a P/E ratio of 20.34 and a beta of 0.85. The firm’s 50-day moving average is $43.77 and its 200 day moving average is $47.21. Innophos Holdings has a 1-year low of $37.02 and a 1-year high of $58.22.
Several institutional investors have recently bought and sold shares of the stock. Barings LLC acquired a new stake in Innophos Holdings during the first quarter valued at approximately $200,000. Private Advisor Group LLC acquired a new stake in Innophos Holdings during the first quarter valued at approximately $200,000. State of Alaska Department of Revenue increased its stake in Innophos Holdings by 81.4% in the first quarter. State of Alaska Department of Revenue now owns 3,810 shares of the specialty chemicals company’s stock valued at $205,000 after buying an additional 1,710 shares during the last quarter. GHP Investment Advisors Inc. acquired a new stake in Innophos Holdings during the first quarter valued at approximately $223,000. Finally, Acrospire Investment Management LLC increased its stake in Innophos Holdings by 28.8% in the first quarter. Acrospire Investment Management LLC now owns 4,507 shares of the specialty chemicals company’s stock valued at $243,000 after buying an additional 1,007 shares during the last quarter. Hedge funds and other institutional investors own 93.82% of the company’s stock.
The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, September 6th. Stockholders of record on Friday, August 18th will be issued a dividend of $0.48 per share. The ex-dividend date of this dividend is Wednesday, August 16th. This represents a $1.92 annualized dividend and a dividend yield of 4.11%. Innophos Holdings’s dividend payout ratio (DPR) is currently 84.21%.
Innophos Holdings Company Profile
Innophos Holdings, Inc is a producer of nutritional specialty ingredients with applications in food, beverage, dietary supplements, pharmaceutical, oral care and industrial end markets. The Company also provides bioactive mineral and nutritional ingredients. The Company’s segments include Specialty Phosphates US & Canada, Specialty Phosphates Mexico, and Granular Triple Super Phosphate (GTSP) & Other.
Receive News & Ratings for Innophos Holdings Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Innophos Holdings Inc. and related companies with MarketBeat.com's FREE daily email newsletter.